Literature DB >> 18063818

Emerging role of microRNAs in cardiovascular biology.

Michael V G Latronico1, Daniele Catalucci, Gianluigi Condorelli.   

Abstract

The heart is among the most conserved organs of the body and is susceptible to defects more than any other organ. Heart malformations, in fact, occur in roughly 1% of newborns. Moreover, cardiovascular disease arising during adult life is among the main causes of morbidity and mortality in developed countries. It is not surprising, therefore, that much effort is being channeled into understanding the development, physiology, and pathology of the cardiovascular system. MicroRNAs, a newly discovered class of small ribonucleotide-based regulators of gene expression, are being implicated in an increasing number of biological processes, and the study of their role in cardiovascular biology is just beginning. Here, we briefly overview microRNAs in general and report on the recent findings regarding their importance for the heart and vasculature, in particular. The new insights that are being gained will permit not only a greater understanding of cardiovascular pathologies but also, hopefully, the development of novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063818     DOI: 10.1161/CIRCRESAHA.107.163147

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  103 in total

Review 1.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

2.  Affinity purification of microRNA-133a with the cardiac transcription factor, Hand2.

Authors:  Ngan K Vo; Ryan P Dalton; Ning Liu; Eric N Olson; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Ahamed A Khalyfa; David Gozal
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

Review 4.  MicroRNA: a new frontier in kidney and blood pressure research.

Authors:  Mingyu Liang; Yong Liu; Domagoj Mladinov; Allen W Cowley; Hariprasad Trivedi; Yi Fang; Xialian Xu; Xiaoqiang Ding; Zhongmin Tian
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

5.  An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples.

Authors:  Xiao Zhang; Jiamin Chen; Tom Radcliffe; Dave P Lebrun; Victor A Tron; Harriet Feilotter
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

Review 6.  MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.

Authors:  Zhen-wei Pan; Yan-jie Lu; Bao-feng Yang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

Review 7.  Emerging role of microRNAs in liver diseases.

Authors:  Shashi Bala; Miguel Marcos; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

8.  NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2.

Authors:  Chuanyu Wei; Li Li; Sudhiranjan Gupta
Journal:  Mol Cell Biochem       Date:  2013-11-01       Impact factor: 3.396

9.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

10.  Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction.

Authors:  Bing Shi; Yanhong Guo; Juan Wang; Wei Gao
Journal:  BMC Cardiovasc Disord       Date:  2010-03-01       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.